Melanie E. Garrett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Melanie E. Garrett has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Allison E. Ashley-Koch
Duke University Medical Center
26 shared publications - Marilyn J. Telen
Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC
11 shared publications - Yingze Zhang
Nankai University, Tianjin, China
7 shared publications - Seyed Mehdi Nouraie
Department of Medicine, University of Pittsburgh, Pittsburgh, PA
6 shared publications - Jennifer A. Smith
Department of Epidemiology, School of Public Health, University of Michigan
5 shared publications - John Blangero
The University of Texas Rio Grande Valley
5 shared publications
Latest Publications
- 15 October 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (20) , 6991-7003
Local ancestry–aware genome-wide meta-analysis uncovers novel genetic loci for sickle cell disease nephropathy
In the United States, sickle cell disease (SCD) is a rare inherited hemoglobinopathy affecting ∼100 000 individuals, mostly with African ancestry. SCD causes damage to multiple organ systems, and SCD nephropathy (SCDN) is a common complication associated with early mortality. We previously performed a genome-wide association study (GWAS) for SCDN and identified a modest number of genome-wide significant loci. Here, we leveraged the ancestral composition of participants from 2 well-characterized adult SCD cohorts to boost statistical power and perform a local ancestry–aware GWAS for estimated glomerular filtration rate, resulting in the identification of novel genome-wide significant loci within the African and European ancestral components of participants. Meta-analysis identified 12 significant genomic regions in the African tract, including peptidylprolyl isomerase like 6, ARHGAP24, RAB11A, and STEAP3, and 38 regions in the European tract, including UBLCP1, a disintegrin and metalloproteinase with thrombospondin motifs 6, JAZF1, MYO7B, MYO1C, PDGFA, GPC5, LRP1B, KANK1, and TRPV5. The identified regions encompass genes affecting inflammation, extracellular matrix integrity, iron metabolism, magnesium ion homeostasis, B-cell apoptosis, tumor necrosis factor production, and estrogen signaling. Many of these genes and pathways are important not only for renal function but also for SCD biology, providing additional support for the hypothesis that SCDN pathophysiology is unique from other forms of kidney disease. This study represents the largest local ancestry–aware analysis of SCDN to date, furthers our understanding of the genetic risk factors underlying SCDN, and proposes new targets that could be useful for the early identification and treatment of kidney dysfunction in patients with SCD.
- 15 October 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (20) , 6991-7003
Local ancestry–aware genome-wide meta-analysis uncovers novel genetic loci for sickle cell disease nephropathy
In the United States, sickle cell disease (SCD) is a rare inherited hemoglobinopathy affecting ∼100 000 individuals, mostly with African ancestry. SCD causes damage to multiple organ systems, and SCD nephropathy (SCDN) is a common complication associated with early mortality. We previously performed a genome-wide association study (GWAS) for SCDN and identified a modest number of genome-wide significant loci. Here, we leveraged the ancestral composition of participants from 2 well-characterized adult SCD cohorts to boost statistical power and perform a local ancestry–aware GWAS for estimated glomerular filtration rate, resulting in the identification of novel genome-wide significant loci within the African and European ancestral components of participants. Meta-analysis identified 12 significant genomic regions in the African tract, including peptidylprolyl isomerase like 6, ARHGAP24, RAB11A, and STEAP3, and 38 regions in the European tract, including UBLCP1, a disintegrin and metalloproteinase with thrombospondin motifs 6, JAZF1, MYO7B, MYO1C, PDGFA, GPC5, LRP1B, KANK1, and TRPV5. The identified regions encompass genes affecting inflammation, extracellular matrix integrity, iron metabolism, magnesium ion homeostasis, B-cell apoptosis, tumor necrosis factor production, and estrogen signaling. Many of these genes and pathways are important not only for renal function but also for SCD biology, providing additional support for the hypothesis that SCDN pathophysiology is unique from other forms of kidney disease. This study represents the largest local ancestry–aware analysis of SCDN to date, furthers our understanding of the genetic risk factors underlying SCDN, and proposes new targets that could be useful for the early identification and treatment of kidney dysfunction in patients with SCD.
- Open Access
Local ancestry-aware genome-wide meta-analysis uncovers novel genetic loci for sickle cell disease nephropathy
In the United States, sickle cell disease (SCD) is a rare inherited hemoglobinopathy affecting about 100,000 individuals, mostly with African ancestry. SCD causes damage to multiple organ systems and SCD nephropathy (SCDN) is a common complication associated with early mortality. We previously performed a genome-wide association study (GWAS) for SCDN and identified a modest number of genome-wide significant loci. Here, we leveraged the ancestral composition of participants from two well-characterized adult SCD cohorts to boost statistical power and perform a local ancestry-aware GWAS for estimated glomerular filtration rate (eGFR), resulting in the identification of novel genome-wide significant loci within the African (AFR) and European (EUR) ancestral components of participants. Meta-analysis identified 12 significant genomic regions in the AFR tract, including PPIL6 , ARHGAP24 , RAB11A , and STEAP3 , and 38 regions in the EUR tract, including UBLCP1 , ADAMTS6 , JAZF1 , MYO7B , MYO1C , PDGFA , GPC5 , LRP1B , KANK1 , and TRPV5 . The identified regions encompass genes affecting inflammation, extracellular matrix (ECM) integrity, iron metabolism, magnesium ion homeostasis, B cell apoptosis, tumor necrosis factor (TNF) production, and estrogen signaling. Many of these genes and pathways are important not only for renal function, but also for SCD biology, providing additional support for the hypothesis that SCDN pathophysiology is unique from other forms of kidney disease. This study represents the largest local ancestry-aware analysis of SCDN to date, furthers our understanding of the genetic risk factors underlying SCDN, and proposes new targets that could be useful for the early identification and treatment of kidney dysfunction in SCD patients. KEY POINTS: Novel application of local ancestry-aware GWAS in two SCD cohorts identified distinct eGFR loci from the African and European ancestries This application increased power to detect new loci with biologic functions important to renal function, as well as sickle cell disease
Open AccessLocal ancestry-aware genome-wide meta-analysis uncovers novel genetic loci for sickle cell disease nephropathy
In the United States, sickle cell disease (SCD) is a rare inherited hemoglobinopathy affecting about 100,000 individuals, mostly with African ancestry. SCD causes damage to multiple organ systems and SCD nephropathy (SCDN) is a common complication associated with early mortality. We previously performed a genome-wide association study (GWAS) for SCDN and identified a modest number of genome-wide significant loci. Here, we leveraged the ancestral composition of participants from two well-characterized adult SCD cohorts to boost statistical power and perform a local ancestry-aware GWAS for estimated glomerular filtration rate (eGFR), resulting in the identification of novel genome-wide significant loci within the African (AFR) and European (EUR) ancestral components of participants. Meta-analysis identified 12 significant genomic regions in the AFR tract, including PPIL6 , ARHGAP24 , RAB11A , and STEAP3 , and 38 regions in the EUR tract, including UBLCP1 , ADAMTS6 , JAZF1 , MYO7B , MYO1C , PDGFA , GPC5 , LRP1B , KANK1 , and TRPV5 . The identified regions encompass genes affecting inflammation, extracellular matrix (ECM) integrity, iron metabolism, magnesium ion homeostasis, B cell apoptosis, tumor necrosis factor (TNF) production, and estrogen signaling. Many of these genes and pathways are important not only for renal function, but also for SCD biology, providing additional support for the hypothesis that SCDN pathophysiology is unique from other forms of kidney disease. This study represents the largest local ancestry-aware analysis of SCDN to date, furthers our understanding of the genetic risk factors underlying SCDN, and proposes new targets that could be useful for the early identification and treatment of kidney dysfunction in SCD patients. KEY POINTS: Novel application of local ancestry-aware GWAS in two SCD cohorts identified distinct eGFR loci from the African and European ancestries This application increased power to detect new loci with biologic functions important to renal function, as well as sickle cell disease
- Open Access
Suicidality phenotypes reflect both shared and distinct genetic factors
Suicidality phenotypes, including suicidal ideation (SI), non-fatal suicide attempt (SA), and suicide death (SD), are heritable and exhibit both shared and phenotype-specific genetic influences. Using genomic structural equation modelling, we estimated the shared genetic architecture across GWAS of SI (176,147 cases, 1,010,300 controls), SA (53,919 cases, 1,063,988 controls), and SD (7,584 cases, 652,070 controls) and conducted a multivariate GWAS of a latent suicidality factor capturing their shared liability. This analysis identified 36 genome-wide significant loci, including seven not previously reported in any suicidality GWAS. Follow-up analyses identified residual genetic variance specific to each phenotype, including three SD-specific genomic risk loci. Conditioning suicidality phenotypes on genetic liability to psychiatric disorders revealed significant residual genetic variance across SI, SA, SD, and the suicidality common factor. Together, these results suggest that suicidality reflects both shared genetic liability and phenotype-specific contributions.
Open AccessSuicidality phenotypes reflect both shared and distinct genetic factors
Suicidality phenotypes, including suicidal ideation (SI), non-fatal suicide attempt (SA), and suicide death (SD), are heritable and exhibit both shared and phenotype-specific genetic influences. Using genomic structural equation modelling, we estimated the shared genetic architecture across GWAS of SI (176,147 cases, 1,010,300 controls), SA (53,919 cases, 1,063,988 controls), and SD (7,584 cases, 652,070 controls) and conducted a multivariate GWAS of a latent suicidality factor capturing their shared liability. This analysis identified 36 genome-wide significant loci, including seven not previously reported in any suicidality GWAS. Follow-up analyses identified residual genetic variance specific to each phenotype, including three SD-specific genomic risk loci. Conditioning suicidality phenotypes on genetic liability to psychiatric disorders revealed significant residual genetic variance across SI, SA, SD, and the suicidality common factor. Together, these results suggest that suicidality reflects both shared genetic liability and phenotype-specific contributions.
- 31 July 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 189, 528-535
Examining the timing of trauma, PTSD onset, and DNA methylation: A multicohort investigation of candidate CpG sites
- 31 July 2025
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 189, 528-535
Examining the timing of trauma, PTSD onset, and DNA methylation: A multicohort investigation of candidate CpG sites
- Open Access
- 8 May 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (5) , e70012
Comparative mapping of single‐cell transcriptomic landscapes in neurodegenerative diseases
INTRODUCTION: Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and Parkinson's disease (PD) represent a spectrum of neurodegenerative diseases (NDDs). Here, we performed the first direct comparison of their transcriptomic landscapes.METHODS: We profiled whole transcriptomes of NDD cortical tissue by single‐nucleus RNA sequencing, using computational analyses to identify common and distinct differentially expressed genes (DEGs), pathways, vulnerable and disease‐driver cell subtypes, and altered cell‐to‐cell interactions.RESULTS: The same inhibitory neuron subtype was depleted in both AD and DLB. Potentially disease‐driving neuronal cell subtypes were identified in both PD and DLB. Cell–cell communication was predicted to be increased in AD but decreased in DLB and PD. DEGs were most commonly shared across NDDs within inhibitory neuron subtypes. Overall, AD and PD showed greatest transcriptomic divergence, while DLB exhibited an intermediate signature.DISCUSSION: These results may help explain the clinicopathological spectrum of these NDDs and provide unique insights into shared and distinct molecular mechanisms underlying pathogenesis.Highlights: The same vulnerable inhibitory neuron subtype population was depleted in both Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Potentially disease‐driving neuronal cell subtypes were discovered in both Parkinson's disease (PD) and DLB. Cell–cell communication was predicted to be increased in AD but decreased in DLB and PD. Differentially expressed genes were most commonly shared across neurodegenerative diseases in inhibitory neuron types. AD and PD had the greatest transcriptomic divergence, with DLB showing an intermediate signature.
- 8 May 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (5) , e70012
Open AccessComparative mapping of single‐cell transcriptomic landscapes in neurodegenerative diseases
INTRODUCTION: Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and Parkinson's disease (PD) represent a spectrum of neurodegenerative diseases (NDDs). Here, we performed the first direct comparison of their transcriptomic landscapes.METHODS: We profiled whole transcriptomes of NDD cortical tissue by single‐nucleus RNA sequencing, using computational analyses to identify common and distinct differentially expressed genes (DEGs), pathways, vulnerable and disease‐driver cell subtypes, and altered cell‐to‐cell interactions.RESULTS: The same inhibitory neuron subtype was depleted in both AD and DLB. Potentially disease‐driving neuronal cell subtypes were identified in both PD and DLB. Cell–cell communication was predicted to be increased in AD but decreased in DLB and PD. DEGs were most commonly shared across NDDs within inhibitory neuron subtypes. Overall, AD and PD showed greatest transcriptomic divergence, while DLB exhibited an intermediate signature.DISCUSSION: These results may help explain the clinicopathological spectrum of these NDDs and provide unique insights into shared and distinct molecular mechanisms underlying pathogenesis.Highlights: The same vulnerable inhibitory neuron subtype population was depleted in both Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Potentially disease‐driving neuronal cell subtypes were discovered in both Parkinson's disease (PD) and DLB. Cell–cell communication was predicted to be increased in AD but decreased in DLB and PD. Differentially expressed genes were most commonly shared across neurodegenerative diseases in inhibitory neuron types. AD and PD had the greatest transcriptomic divergence, with DLB showing an intermediate signature.
- 22 April 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 80 (7)
Accelerated Epigenetic Aging and Prospective Morbidity and Mortality Among U.S. Veterans
Background: Epigenetic aging measures have promise as surrogate health outcomes in randomized control trials and observational cohort studies. The value of these measures, however, will reflect the extent to which they are associated with prospective health outcomes in real-world medical settings. Methods: Using data from 2 216 post-9/11 veterans from the VISN 6 MIRECC’s Post-Deployment Mental Health Study, we examined whether accelerated epigenetic aging, assessed by DunedinPACE, was associated with prospective chronic disease morbidity, predicted healthcare costs, and mortality over an average of 13.1 years of electronic health record follow-up. Results: Veterans with faster DunedinPACE aging scores developed more chronic disease over the subsequent 5 years (RR, 1.25; 95% CI, 1.14–1.36), 10 years (RR, 1.31; 95% CI, 1.21–1.40), and 15 years (RR, 1.36; 95% CI, 1.22–1.52). Faster aging scores were also associated with increases in predicted healthcare costs over the next 5 years (β = 0.08; 95% CI, 0.03–0.13), 10 years (β = 0.23, 95% CI, 0.15–0.31), and 15 years (β = 0.21; 95% CI, 0.11–0.30). Faster DunedinPACE aging scores were associated with greater risk for incident myocardial infarction (84%), stroke (38%), diabetes (56%), cancer (25%), liver disease (44%), and renal disease (34%), as well as greater risk of mortality due to all-causes (38%) and chronic disease (74%). These results remained when adjusting for demographic, biomarker, and smoking covariates. Conclusions: Our findings suggest DunedinPACE is a biomarker of accelerated aging that is prospectively associated with chronic disease morbidity and mortality, as assessed using health records from an integrated healthcare system.
- 22 April 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 80 (7)
Accelerated Epigenetic Aging and Prospective Morbidity and Mortality Among U.S. Veterans
Background: Epigenetic aging measures have promise as surrogate health outcomes in randomized control trials and observational cohort studies. The value of these measures, however, will reflect the extent to which they are associated with prospective health outcomes in real-world medical settings. Methods: Using data from 2 216 post-9/11 veterans from the VISN 6 MIRECC’s Post-Deployment Mental Health Study, we examined whether accelerated epigenetic aging, assessed by DunedinPACE, was associated with prospective chronic disease morbidity, predicted healthcare costs, and mortality over an average of 13.1 years of electronic health record follow-up. Results: Veterans with faster DunedinPACE aging scores developed more chronic disease over the subsequent 5 years (RR, 1.25; 95% CI, 1.14–1.36), 10 years (RR, 1.31; 95% CI, 1.21–1.40), and 15 years (RR, 1.36; 95% CI, 1.22–1.52). Faster aging scores were also associated with increases in predicted healthcare costs over the next 5 years (β = 0.08; 95% CI, 0.03–0.13), 10 years (β = 0.23, 95% CI, 0.15–0.31), and 15 years (β = 0.21; 95% CI, 0.11–0.30). Faster DunedinPACE aging scores were associated with greater risk for incident myocardial infarction (84%), stroke (38%), diabetes (56%), cancer (25%), liver disease (44%), and renal disease (34%), as well as greater risk of mortality due to all-causes (38%) and chronic disease (74%). These results remained when adjusting for demographic, biomarker, and smoking covariates. Conclusions: Our findings suggest DunedinPACE is a biomarker of accelerated aging that is prospectively associated with chronic disease morbidity and mortality, as assessed using health records from an integrated healthcare system.
- Open Access
- 11 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Whole genome sequencing analysis of body mass index identifies novel African ancestry-specific risk allele
Obesity is a major public health crisis associated with high mortality rates. Previous genome-wide association studies (GWAS) investigating body mass index (BMI) have largely relied on imputed data from European individuals. This study leveraged whole-genome sequencing (WGS) data from 88,873 participants from the Trans-Omics for Precision Medicine (TOPMed) Program, of which 51% were of non-European population groups. We discovered 18 BMI-associated signals (P < 5 × 10− 9), including two secondary signals. Notably, we identified and replicated a novel low-frequency single nucleotide polymorphism (SNP) in MTMR3 that was common in individuals of African descent. Using a diverse study population, we further identified two novel secondary signals in known BMI loci and pinpointed two likely causal variants in the POC5 and DMD loci. Our work demonstrates the benefits of combining WGS and diverse cohorts in expanding current catalog of variants and genes confer risk for obesity, bringing us one step closer to personalized medicine.
- 11 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessWhole genome sequencing analysis of body mass index identifies novel African ancestry-specific risk allele
Obesity is a major public health crisis associated with high mortality rates. Previous genome-wide association studies (GWAS) investigating body mass index (BMI) have largely relied on imputed data from European individuals. This study leveraged whole-genome sequencing (WGS) data from 88,873 participants from the Trans-Omics for Precision Medicine (TOPMed) Program, of which 51% were of non-European population groups. We discovered 18 BMI-associated signals (P < 5 × 10− 9), including two secondary signals. Notably, we identified and replicated a novel low-frequency single nucleotide polymorphism (SNP) in MTMR3 that was common in individuals of African descent. Using a diverse study population, we further identified two novel secondary signals in known BMI loci and pinpointed two likely causal variants in the POC5 and DMD loci. Our work demonstrates the benefits of combining WGS and diverse cohorts in expanding current catalog of variants and genes confer risk for obesity, bringing us one step closer to personalized medicine.
- 2 January 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (1)
Accelerated biological aging and midlife frailty among U.S. military veterans
Injuries characterizing recent military service, such as traumatic brain injury and posttraumatic stress disorder, are linked to accelerated biological aging. If recent veterans have accelerated aging, they might also show early onset of aging-related phenotypes, such as frailty. In this study, we examined the prevalence of frailty and associations with biological aging using data from 1,654 post-9/11 veterans, who were followed for an average of 12.6 years. Biological aging was assessed using DunedinPACE, and frailty was assessed using 11 years of Jen Frailty Index scores from electronic health records. We found a high proportion of frailty—25.5% of post-9/11 veterans met frailty criteria during the study. This is roughly double the prevalence among community-dwelling older adults, despite the cohort’s average age of 50.2 years at study end. Veterans with faster aging had higher initial frailty scores (β, 0.21; 95% CI, 0.15–0.27), higher peak frailty scores (β, 0.24; 95% CI, 0.18–0.30), and larger increases in frailty scores over time (β, 0.15; 95% CI, 0.09–0.21, all ps < .001). Faster aging was associated with a 62% (95% CI, 44%–82%) greater rate of incident frailty over the follow-up, while accounting for demographics, baseline health, and smoking. These results suggest post-9/11 veterans are at risk of early onset frailty, and this increased risk could be explained by accelerated rates of biological aging. Future research should replicate these results in nationally representative samples of post-9/11 veterans and explore whether screening for frailty should be implemented at younger ages for veterans.
- 2 January 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (1)
Accelerated biological aging and midlife frailty among U.S. military veterans
Injuries characterizing recent military service, such as traumatic brain injury and posttraumatic stress disorder, are linked to accelerated biological aging. If recent veterans have accelerated aging, they might also show early onset of aging-related phenotypes, such as frailty. In this study, we examined the prevalence of frailty and associations with biological aging using data from 1,654 post-9/11 veterans, who were followed for an average of 12.6 years. Biological aging was assessed using DunedinPACE, and frailty was assessed using 11 years of Jen Frailty Index scores from electronic health records. We found a high proportion of frailty—25.5% of post-9/11 veterans met frailty criteria during the study. This is roughly double the prevalence among community-dwelling older adults, despite the cohort’s average age of 50.2 years at study end. Veterans with faster aging had higher initial frailty scores (β, 0.21; 95% CI, 0.15–0.27), higher peak frailty scores (β, 0.24; 95% CI, 0.18–0.30), and larger increases in frailty scores over time (β, 0.15; 95% CI, 0.09–0.21, all ps < .001). Faster aging was associated with a 62% (95% CI, 44%–82%) greater rate of incident frailty over the follow-up, while accounting for demographics, baseline health, and smoking. These results suggest post-9/11 veterans are at risk of early onset frailty, and this increased risk could be explained by accelerated rates of biological aging. Future research should replicate these results in nationally representative samples of post-9/11 veterans and explore whether screening for frailty should be implemented at younger ages for veterans.
- Open Access
- 19 September 2024
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 79 (11)
Black Americans With Sickle Cell Disease (SCD) Demonstrate Accelerated Epigenetic Pace of Aging Compared to Black Americans Without SCD
Sickle cell disease (SCD) is a chronic medical condition characterized by red blood cell sickling, vaso-occlusion, hemolytic anemia, and subsequently, end-organ damage and reduced survival. Because of this significant pathophysiology and early mortality, we hypothesized that patients with SCD are experiencing accelerated biological aging compared to individuals without SCD. We utilized the DunedinPACE measure to compare the epigenetic pace of aging in 131 Black Americans with SCD to 1391 Black American veterans without SCD. SCD patients displayed a significantly accelerated pace of aging (DunedinPACE mean difference of 0.057 points) compared to the veterans without SCD, whereby SCD patients were aging approximately 0.7 months more per year than those without SCD (p=4.49x10-8). This was true, even though the SCD patients were significantly younger according to chronological age than the individuals without SCD, making the epigenetic aging discrepancy even more apparent. This association became stronger when we removed individuals with PTSD from the non-SCD group (p=2.18x10-9), and stronger still when we restricted the SCD patients to those with hemoglobin SS and Sβ0 thalassemia genotypes (p=1.61x10-10). These data support our hypothesis that individuals with SCD experience accelerated biological aging as measured by global epigenetic variation. The assessment of epigenetic measures of biological aging may prove useful to identify which SCD patients would most benefit from clinical interventions to reduce mortality.
- 19 September 2024
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 79 (11)
Open AccessBlack Americans With Sickle Cell Disease (SCD) Demonstrate Accelerated Epigenetic Pace of Aging Compared to Black Americans Without SCD
Sickle cell disease (SCD) is a chronic medical condition characterized by red blood cell sickling, vaso-occlusion, hemolytic anemia, and subsequently, end-organ damage and reduced survival. Because of this significant pathophysiology and early mortality, we hypothesized that patients with SCD are experiencing accelerated biological aging compared to individuals without SCD. We utilized the DunedinPACE measure to compare the epigenetic pace of aging in 131 Black Americans with SCD to 1391 Black American veterans without SCD. SCD patients displayed a significantly accelerated pace of aging (DunedinPACE mean difference of 0.057 points) compared to the veterans without SCD, whereby SCD patients were aging approximately 0.7 months more per year than those without SCD (p=4.49x10-8). This was true, even though the SCD patients were significantly younger according to chronological age than the individuals without SCD, making the epigenetic aging discrepancy even more apparent. This association became stronger when we removed individuals with PTSD from the non-SCD group (p=2.18x10-9), and stronger still when we restricted the SCD patients to those with hemoglobin SS and Sβ0 thalassemia genotypes (p=1.61x10-10). These data support our hypothesis that individuals with SCD experience accelerated biological aging as measured by global epigenetic variation. The assessment of epigenetic measures of biological aging may prove useful to identify which SCD patients would most benefit from clinical interventions to reduce mortality.
- Open Access
- 18 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0306399
A study protocol for risk stratification in children with concussion (RSiCC): Theoretical framework, design, and methods
Research shows that one in five children will experience a concussion by age 16. Compared to adults, children experience longer and more severe postconcussive symptoms (PCS), with severity and duration varying considerably among children and complicating management of these patients. Persistent PCS can result in increased school absenteeism, social isolation, and psychological distress. Although early PCS diagnosis and access to evidence-based interventions are strongly linked to positive health and academic outcomes, symptom severity and duration are not fully explained by acute post-injury symptoms. Prior research has focused on the role of neuroinflammation in mediating PCS and associated fatigue; however relationship between inflammatory biomarkers and PCS severity, has not examined longitudinally. To identify which children are at high risk for persistent PCS and poor health, academic, and social outcomes, research tracking PCS trajectories and describing school-based impacts across the entire first year postinjury is critically needed. This study will 1) define novel PCS trajectory typologies in a racially/ethnically diverse population of 500 children with concussion (11–17 years, near equal distribution by sex), 2) identify associations between these typologies and patterns of inflammatory biomarkers and genetic variants, 3) develop a risk stratification model to identify children at risk for persistent PCS; and 4) gain unique insights and describe PCS impact, including fatigue, on longer-term academic and social outcomes. We will be the first to use NIH’s symptom science model and patient-reported outcomes to explore the patterns of fatigue and other physical, cognitive, psychological, emotional and academic responses to concussion in children over a full year. Our model will enable clinicians and educators to identify children most at risk for poor long-term health, social, and academic outcomes after concussion. This work is critical to meeting our long-term goal of developing personalized concussion symptom-management strategies to improve outcomes and reduce disparities in the health and quality of life of children.
- 18 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0306399
Open AccessA study protocol for risk stratification in children with concussion (RSiCC): Theoretical framework, design, and methods
Research shows that one in five children will experience a concussion by age 16. Compared to adults, children experience longer and more severe postconcussive symptoms (PCS), with severity and duration varying considerably among children and complicating management of these patients. Persistent PCS can result in increased school absenteeism, social isolation, and psychological distress. Although early PCS diagnosis and access to evidence-based interventions are strongly linked to positive health and academic outcomes, symptom severity and duration are not fully explained by acute post-injury symptoms. Prior research has focused on the role of neuroinflammation in mediating PCS and associated fatigue; however relationship between inflammatory biomarkers and PCS severity, has not examined longitudinally. To identify which children are at high risk for persistent PCS and poor health, academic, and social outcomes, research tracking PCS trajectories and describing school-based impacts across the entire first year postinjury is critically needed. This study will 1) define novel PCS trajectory typologies in a racially/ethnically diverse population of 500 children with concussion (11–17 years, near equal distribution by sex), 2) identify associations between these typologies and patterns of inflammatory biomarkers and genetic variants, 3) develop a risk stratification model to identify children at risk for persistent PCS; and 4) gain unique insights and describe PCS impact, including fatigue, on longer-term academic and social outcomes. We will be the first to use NIH’s symptom science model and patient-reported outcomes to explore the patterns of fatigue and other physical, cognitive, psychological, emotional and academic responses to concussion in children over a full year. Our model will enable clinicians and educators to identify children most at risk for poor long-term health, social, and academic outcomes after concussion. This work is critical to meeting our long-term goal of developing personalized concussion symptom-management strategies to improve outcomes and reduce disparities in the health and quality of life of children.